Purification, Identification, and In Silico Analysis of Anti-Obesity and Antidiabetic Peptides from the Red Seaweed Palmaria palmata
Marine Drugs · 03.10.2025 · 23 (10) · 392
DOI: 10.3390/md23100392 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 03.10.2025. Verfasst von Sakhi Ghelichi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Group for Bioactives-Analysis and Application, National Food Institute, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Anti-Obesity Agents, Peptides, Plant Extracts. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union.
Abstract (Originalsprache)
This study investigates the anti-obesity and antidiabetic potential of P. palmata extracts produced through sequential enzymatic and alkaline treatments. Among the treatment groups, the extract treated solely with Alcalase® (Alc) demonstrated the highest protein content (10.11 ± 0.15%) and degree of hydrolysis (30.36 ± 0.77%), significantly outperforming other treatments (p < 0.05). The Alc extract also exhibited superior inhibitory activity against porcine pancreatic lipase and α-amylase, achieving the lowest IC50 for lipase (2.29 ± 0.87 mg.mL−1) and showing significant enzyme inhibition across all tested concentrations (p < 0.05). Ultrafiltration of the Alc extract revealed that peptide fractions < 1 kDa and 1–3 kDa were most effective in enzyme inhibition, with IC50 values of 3.25–3.55 mg.mL−1 for both lipase and α-amylase. Peptides were identified via LC-MS/MS analysis and database searching using SequestHT, resulting in 536 sequences, of which bioinformatic screening yielded 51 non-toxic, non-allergenic candidates (PeptideRanker score > 0.6); four of these contained known inhibitory motifs for lipase and α-amylase. Molecular docking confirmed strong binding affinities between these peptides and their respective enzymes, supporting their potential as natural enzyme inhibitors. These findings indicate the functional food potential of Alcalase®-derived P. palmata peptides for managing obesity and type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Group for Bioactives-Analysis and Application, National Food Institute, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
- Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
- Enzyme and Protein Chemistry, Department of Biotechnology and Biomedicine, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
ORCID-Profile: Sakhi Ghelichi, Mona Hajfathalian, Seyed Hossein Helalat, Birte Svensson, Charlotte Jacobsen
Förderung
- European Union
Zitieren
APA
Ghelichi, S., Hajfathalian, M., Helalat, S. H., Svensson, B., & Jacobsen, C. (2025). Purification, Identification, and In Silico Analysis of Anti-Obesity and Antidiabetic Peptides from the Red Seaweed Palmaria palmata. Marine Drugs, 23(10), 392. https://doi.org/10.3390/md23100392
Vancouver
Ghelichi S, Hajfathalian M, Helalat SH, Svensson B, Jacobsen C. Purification, Identification, and In Silico Analysis of Anti-Obesity and Antidiabetic Peptides from the Red Seaweed Palmaria palmata. Marine Drugs. 2025;23(10):392. doi:10.3390/md23100392
BibTeX
@article{Ghelichi2025,
author = {Ghelichi, Sakhi and Hajfathalian, Mona and Helalat, Seyed Hossein and Svensson, Birte and Jacobsen, Charlotte},
title = {Purification, Identification, and In Silico Analysis of Anti-Obesity and Antidiabetic Peptides from the Red Seaweed Palmaria palmata},
journal = {Marine Drugs},
year = {2025},
volume = {23},
number = {10},
pages = {392},
doi = {10.3390/md23100392}
}
EUVIMED